Soraia Lobo-Martins, Medical Advisor and Medical Research Fellow, Institut Jules Bordet, shared a post on LinkedIn:
“New publication in Nature Reviews Clinical Oncology, Springer Nature
I am very pleased to share our newly published review on Tailoring targeted therapies for younger premenopausal women with ER-positive early breast cancer.
We discuss how 𝗱𝗶𝘀𝘁𝗶𝗻𝗰𝘁 𝗴𝗲𝗻𝗼𝗺𝗶𝗰, 𝗵𝗼𝗿𝗺𝗼𝗻𝗮𝗹 𝗮𝗻𝗱 𝗶𝗺𝗺𝘂𝗻𝗲 𝗳𝗲𝗮𝘁𝘂𝗿𝗲𝘀 should guide treatment escalation and de-escalation strategies – beyond chronological age alone.
Grateful to collaborate with Stephen J. Luen, Martine Piccart and Sherene Loi.”
Title: Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer
Authors: Soraia Lobo-Martins, Stephen J. Luen, Martine Piccart and Sherene Loi
More posts featuring Soraia Lobo-Martins